The Riverside Company, a global investment firm focused on the smaller end of the middle market, announces it has sold its investment in Red Nucleus, a leading global strategic partner to the life sciences industry, to Thomas H. Lee Partners, a Boston-based private investment firm.  

Read full press release here.